Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript May 12, 2025
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $0.16, expectations were $0.08.
Operator: Greetings, and welcome to the Aurinia Pharmaceuticals Inc. Q1 2025 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to Andrea Christopher, Corporate...
